Two Republican nominees for seats on the Federal Trade Commission were grilled at their Senate confirmation hearing Wednesday on how aggressively the FTC should regulate pharmacy benefit managers—the so called "middle men" in the pharmaceutical supply chain.

"Having access to affordable prescription drugs is an important issue for Americans," Melissa Holyoak told the Senate Committee on Commerce, Science, and Transportation. Holyoak, now Utah's solicitor general, said she supports the agency taking a more aggressive stance in regulating the industry.